by Sandra L. Chase, B.S., Pharm.D., Co-Chair, MSHP Educational Affairs Committee
The 2011 Michigan Pharmacists Association (MPA) Annual Convention & Exposition took place on Feb. 25-27 at the Detroit Marriott at the Renaissance Center. MSHP programming at this year’s event successfully accomplished the goal of defending the profession and advancing pharmacy.
Speakers demonstrated the need for pharmacists and the importance of their clinical roles, as well informed all attendees of the latest therapies. Shawna Kraft, Pharm.D., clinical pharmacist, hematology/oncology, University of Michigan College of Pharmacy, kicked off MSHP programming with “The New, the Old and the Bold: New Drugs in Oncology and an Update from American Society of Hematology 2010.” Oncology agents are very complex and detailed with advanced mechanisms of action and significant toxicity implications. Kraft put this into perspective for the attendees and explained the current clinical trials where these agents are being utilized.
Justine Coffey, JD, LLM, director, section of home, ambulatory and chronic care practitioners, American Society of Health-System Pharmacists (ASHP), joined Michigan pharmacists from Bethesda, Maryland. She gave a very timely presentation on risk evaluation and mitigation strategies, something all pharmacists are dealing with at their institutions. Her presentation helped to clarify the processes needed for the erythropoietin stimulating agents (ESAs) for oncology patients, as well as answered questions on the use of medication guides in health-systems.
The documentation for ESAs is quite extensive and relies on pharmacists taking the lead and making sure hospitals continue to receive a supply of ESAs. The fact that medication guides do not have to be given to patients in the hospital was a sigh of relief for pharmacists.
The last session of MSHP programming was the Clinical Pearls: Cardiology, Infectious Diseases and Emergency Medicine session. Adam Drzewicki, Pharm.D. from Borgess Medical Center; Jesse Hogue, Pharm.D. from Bronson Methodist Hospital; and Michael Tiberg, Pharm.D., BCPS-ID, from Munson Medical Center presented the latest and greatest pearls from these therapeutic areas to a large group of attendees. Drzewicki reviewed the latest cardiology clinical trials and gave the group insights on the role of dronedarone and dabigatran in the treatment of atrial fibrillation and nesiritide for heart failure. Tiberg provided an update on the Infectious Diseases Society of America Guidelines on Methicillin-resistant Staphylococcus aureus. In addition, Hogue presented a patient case to describe the role of the pharmacist in the emergency department and highlight the agents used in rapid sequence intubation and the prevention of infection in patients with open fractures.
Once again, the MPA Annual Convention provided many outstanding opportunities for professional growth and development, as well as a chance to network with colleagues. The continuing education programs provided by MPA and its practice sections strengthened the pharmaceutical care skills and abilities of those attending. MSHP was pleased to contribute to the Convention programming.
Mark your calendar for the 2012 Annual Convention, Feb. 24-26 at the Detroit Marriott at the Renaissance Center!